Dental Care Clinics in Mitchell, SD Accepting Medicare
9 Dental Care Clinics found. Showing 1 - 9
 Hart Family Dental Dentist Medicare: Not Enrolled in Medicare Practice Location: 501 S Ohlman St, Mitchell, SD 57301 Phone: 605-996-0650 |
Dental Health Partners Dentist - General Practice Medicare: Not Enrolled in Medicare Practice Location: 240 E. 23rd Avenue, Mitchell, SD 57301 Phone: 605-996-1316 Fax: 605-996-6629 |
Dr John S Wingfield Pc Dentist - General Practice Medicare: Not Enrolled in Medicare Practice Location: 510 West Havens St, Mitchell, SD 57301 Phone: 605-996-6211 Fax: 605-996-6213 |
Dental Health Partners Dentist - General Practice Medicare: Not Enrolled in Medicare Practice Location: 240 E 23rd St, Mitchell, SD 57301 Phone: 605-996-1316 Fax: 605-996-6629 |
Dr. Brett T. Farnham, Prof., Llc Dentist Medicare: Not Enrolled in Medicare Practice Location: 2110 N Minnesota St, Mitchell, SD 57301 Phone: 605-996-9944 Fax: 605-996-3426 |
The Dental Clinic Dentist Medicare: Not Enrolled in Medicare Practice Location: 1920 North Kimball, Mitchell, SD 57301 Phone: 605-996-7786 Fax: 605-996-5895 |
Dental Care Center Dentist - General Practice Medicare: Not Enrolled in Medicare Practice Location: 916 S Rowley St, Mitchell, SD 57301 Phone: 605-996-1223 Fax: 605-996-1670 |
Dailey Dental Inc Dentist - General Practice Medicare: Not Enrolled in Medicare Practice Location: 1416 N Sanborn Blvd, Mitchell, SD 57301 Phone: 605-996-2228 |
Dental Health Partners Dentist Medicare: Not Enrolled in Medicare Practice Location: 115 W 12th Ave, Mitchell, SD 57301 Phone: 605-996-1316 Fax: 605-996-6629 |
News Archive
Alimera Sciences starts pilot study of Iluvien intravitreal insert
Alimera Sciences, Inc., a privately held biopharmaceutical company that specializes in the research, development and commercialization of prescription ophthalmic pharmaceuticals, today reported that enrollment has begun for a pilot study to assess the safety and efficacy of Iluvien(R) in patients with macular edema secondary to retinal vein occlusion.
TSRI scientists awarded grant to develop new therapeutic approaches for lung cancer
Scientists from the Florida campus of The Scripps Research Institute have been awarded approximately $1.8 million from the National Cancer Institute of the National Institutes of Health to identify the signaling pathways that underlie lung cancer and to use this information to develop new therapeutic approaches.
Impax third quarter net income increases from $6.7 million to $75.2 million
Impax Laboratories, Inc. today reported adjusted net revenue in the third quarter of 2010, excluding the effect of a change in accounting for revenue received under the Company's Strategic Alliance Agreement with Teva, increased $42.6 million to $107.6 million compared to the prior year period, driven by sales of generic Adderall XR for which there were no sales in the third quarter of 2009, as well as increased sales of the Company's fenofibrate products.
Arts-based program identifies safety needs of children from low-income communities
Identifying the public health and safety needs of children from low-income communities may be best accomplished through art, report University of Pittsburgh researchers in the current online issue of Progress in Community Health Partnerships: Research, Education and Action. In their paper, researchers describe the success of Visual Voices, an arts-based program that engages community members as partners in research.
› Verified 6 days ago